Injective (INJ) Extends Breakout Gains as Analyst Maps $14 Target

Injective (INJ) has risen more than 30% since breaking out of a cup-and-handle pattern, while a market analyst’s chart projection places a possible target near $14.

Market analyst Ali Charts projected the target from the pattern. A cup-and-handle typically has a rounded base followed by a short pullback; traders may estimate a target by measuring the cup’s depth. The $14 figure is a chart projection above INJ’s reported 2026 high of $9.37 on Oct. 16.

INJ reached $9.37 on Hyperliquid on Oct. 16, its highest price of the year. Open interest in Hyperliquid’s INJ contracts rose 49.5% over the 24-hour period, increasing about $4.19 million to roughly $12.65 million. The earlier report on INJ’s 2026 high detailed the price move and contract activity.

Injective’s revenue-to-fully diluted valuation ratio was ahead of Solana’s, more than 20% higher than Arbitrum’s, more than eight times Ethereum’s, and more than 10 times Sui’s and Avalanche’s. The ratio compares network revenue with the value of all tokens at full supply.

Onchain revenue feeds Injective’s monthly INJ Community BuyBack, which permanently removes tokens from supply. Injective expects revenue to accelerate as it brings tokenization initiatives onchain and launches new products in the coming months.